Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Diabetes Care
|
June 14, 2023
Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study
Wajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, et al.
CMAJ Open
|
December 20, 2018
Pharmaceutical cannabinoid use in Manitoba, 2004/05 to 2014/15: a population-based cross-sectional study
Wajd Alkabbani, Ruth Ann Marrie, Shawn Bugden, et al.
Alzheimer'S Research & Therapy
|
December 20, 2025
Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study
Che-Yuan Wu, Wajd Alkabbani, Baiju R Shah, et al.
Biomedicine Hub
|
July 17, 2024
Use of Potentially Inappropriate Medications among Older Adults with Dementia or Cognitive Impairment Attending Memory Clinics: A Protocol for a Systematic Review and Meta-Analysis
Rishabh Sharma, Jasdeep Kaur Gill, Caitlin Carter, et al.
Journal of Alzheimer'S Disease : JAD
|
October 11, 2024
Prevalence of Potentially Inappropriate Medications in Older Adults with Cognitive Impairment or Dementia Attending Memory Clinics: A Systematic Review and Meta-Analysis
Rishabh Sharma, Jasdeep Kaur Gill, Manik Chhabra, et al.
Diabetes, Obesity & Metabolism
|
June 5, 2026
Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study
Wajd Alkabbani, Salvatore Crisafulli, Julie M Paik, et al.
BMJ Open Diabetes Research & Care
|
December 15, 2021
Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study
Wajd Alkabbani, Arsene Zongo, Jasjeet K Minhas-Sandhu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 23, 2022
Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus
Wajd Alkabbani, Arsène Zongo, Jasjeet K Minhas-Sandhu, et al.
Canadian Journal of Diabetes
|
May 6, 2022
Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score-matched Population-based Cohort Study
Wajd Alkabbani, Arsène Zongo, Jasjeet K Minhas-Sandhu, et al.
Diabetes & Metabolism
|
November 22, 2021
Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs
Wajd Alkabbani, John-Michael Gamble, Dean T Eurich, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Diabetes Care
|
June 14, 2023
Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study
Wajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, et al.
CMAJ Open
|
December 20, 2018
Pharmaceutical cannabinoid use in Manitoba, 2004/05 to 2014/15: a population-based cross-sectional study
Wajd Alkabbani, Ruth Ann Marrie, Shawn Bugden, et al.
Alzheimer'S Research & Therapy
|
December 20, 2025
Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study
Che-Yuan Wu, Wajd Alkabbani, Baiju R Shah, et al.
Biomedicine Hub
|
July 17, 2024
Use of Potentially Inappropriate Medications among Older Adults with Dementia or Cognitive Impairment Attending Memory Clinics: A Protocol for a Systematic Review and Meta-Analysis
Rishabh Sharma, Jasdeep Kaur Gill, Caitlin Carter, et al.
Journal of Alzheimer'S Disease : JAD
|
October 11, 2024
Prevalence of Potentially Inappropriate Medications in Older Adults with Cognitive Impairment or Dementia Attending Memory Clinics: A Systematic Review and Meta-Analysis
Rishabh Sharma, Jasdeep Kaur Gill, Manik Chhabra, et al.
Diabetes, Obesity & Metabolism
|
June 5, 2026
Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study
Wajd Alkabbani, Salvatore Crisafulli, Julie M Paik, et al.
BMJ Open Diabetes Research & Care
|
December 15, 2021
Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study
Wajd Alkabbani, Arsene Zongo, Jasjeet K Minhas-Sandhu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 23, 2022
Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus
Wajd Alkabbani, Arsène Zongo, Jasjeet K Minhas-Sandhu, et al.
Canadian Journal of Diabetes
|
May 6, 2022
Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score-matched Population-based Cohort Study
Wajd Alkabbani, Arsène Zongo, Jasjeet K Minhas-Sandhu, et al.
Diabetes & Metabolism
|
November 22, 2021
Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs
Wajd Alkabbani, John-Michael Gamble, Dean T Eurich, et al.
Page
of 4